CN113491678A - 一种盐酸阿比朵尔吸入剂及其制备方法 - Google Patents
一种盐酸阿比朵尔吸入剂及其制备方法 Download PDFInfo
- Publication number
- CN113491678A CN113491678A CN202010264939.4A CN202010264939A CN113491678A CN 113491678 A CN113491678 A CN 113491678A CN 202010264939 A CN202010264939 A CN 202010264939A CN 113491678 A CN113491678 A CN 113491678A
- Authority
- CN
- China
- Prior art keywords
- inhalant
- parts
- phospholipid
- arbidol hydrochloride
- coating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010264939.4A CN113491678B (zh) | 2020-04-07 | 2020-04-07 | 一种盐酸阿比朵尔吸入剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010264939.4A CN113491678B (zh) | 2020-04-07 | 2020-04-07 | 一种盐酸阿比朵尔吸入剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113491678A true CN113491678A (zh) | 2021-10-12 |
CN113491678B CN113491678B (zh) | 2023-01-20 |
Family
ID=77994654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010264939.4A Active CN113491678B (zh) | 2020-04-07 | 2020-04-07 | 一种盐酸阿比朵尔吸入剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113491678B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101389319A (zh) * | 2006-02-23 | 2009-03-18 | 埃里莫斯医药品有限公司 | 治疗流感病毒感染的方法 |
US20090155349A1 (en) * | 2006-02-23 | 2009-06-18 | Jonathan Daniel Heller | Methods of treating influenza viral infections |
CN103446051A (zh) * | 2013-08-26 | 2013-12-18 | 陈永奇 | 含有帕拉米韦和/或其衍生物制剂的给药方法 |
CN106659689A (zh) * | 2014-08-29 | 2017-05-10 | 阿尔吉法玛公司 | 海藻酸盐寡聚物的可吸入粉末配制品 |
-
2020
- 2020-04-07 CN CN202010264939.4A patent/CN113491678B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101389319A (zh) * | 2006-02-23 | 2009-03-18 | 埃里莫斯医药品有限公司 | 治疗流感病毒感染的方法 |
US20090155349A1 (en) * | 2006-02-23 | 2009-06-18 | Jonathan Daniel Heller | Methods of treating influenza viral infections |
CN103446051A (zh) * | 2013-08-26 | 2013-12-18 | 陈永奇 | 含有帕拉米韦和/或其衍生物制剂的给药方法 |
CN106659689A (zh) * | 2014-08-29 | 2017-05-10 | 阿尔吉法玛公司 | 海藻酸盐寡聚物的可吸入粉末配制品 |
Also Published As
Publication number | Publication date |
---|---|
CN113491678B (zh) | 2023-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10912821B2 (en) | Diketopiperazine salts for drug delivery and related methods | |
US20220152145A1 (en) | Method and formulation for inhalation | |
US20190022053A1 (en) | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) | |
AU2002218503B2 (en) | Powdery preparations and methods for producing the same | |
US8614255B2 (en) | Pulmonary pharmaceutical formulations | |
CN111991375A (zh) | 一种雾化吸入用瑞德西韦脂质体及其制备方法 | |
EP3932400A1 (en) | Peramivir solution type inhalant and preparation method therefor | |
CA2750371A1 (en) | Dry powder pharmaceutical composition for inhalation | |
CN113491678B (zh) | 一种盐酸阿比朵尔吸入剂及其制备方法 | |
US20240050450A1 (en) | Inhalable Cannabinoid Formulations | |
CN113491677B (zh) | 一类药用抗病毒药物吸入剂新型制剂及制备方法 | |
EP2411008B1 (en) | Complexes of tiotropium with improved properties of solubility and stability | |
WO2022235750A1 (en) | Delivery of cellular material and other material as a dry powder | |
JP2002284703A (ja) | 粉末製剤 | |
CN117427051A (zh) | 褪黑素干粉吸入制剂及其制备方法 | |
AU2012203627B2 (en) | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery | |
CN116407524A (zh) | 一种莫那比拉韦吸入粉雾剂及其制备方法 | |
AU2015200729A1 (en) | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221212 Address after: Room 402-5, Building 1, Modern Pharmaceutical Port (South District), Changjiang Road, Development Zone, Heze City, Shandong Province, 274000 Applicant after: Zhihe (Shandong) Pharmaceutical Factory Co.,Ltd. Address before: 518103 320, Jinhao building, No. 109, Fuyong section, Guangshen Road, Fenghuang community, Fuyong street, Bao'an District, Shenzhen, Guangdong Province Applicant before: Diskaiwei (Shenzhen) new drug development Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230907 Address after: Units a43-3 and 4, No. 199, Mufu East Road, Gulou District, Nanjing, Jiangsu 210000 Patentee after: Nanjing Zhihe Medical Technology Co.,Ltd. Address before: Room 402-5, Building 1, Modern Pharmaceutical Port (South District), Changjiang Road, Development Zone, Heze City, Shandong Province, 274000 Patentee before: Zhihe (Shandong) Pharmaceutical Factory Co.,Ltd. |
|
TR01 | Transfer of patent right |